22 May 2013
Keywords: merck, kgaa, invests, developing, its, cancer, treatment
Article | 28 March 2005
German pharmaceutical firm Merck KGaA has outlined plans to step up an ambitious clinical trial program for its leading cancer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 March 2005
21 March 2005
4 April 2005
© 2013 thepharmaletter.com